Aziyo Biologics, Inc. (AZYO) Financial Analysis & Valuation | Quarter Chart
Aziyo Biologics, Inc. (AZYO)
AZYOPrice: $1.49
Fair Value: 🔒
🔒score
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibi... more
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative m... more
Description
Shares
| Market Cap | $24.21M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | C. Randal Mills |
| IPO Date | 2020-10-08 | CAGR | -0.15% |
| Employees | 151 | Website | www.aziyo.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
AZYO chart loading...
Fundamentals
Technicals
| Enterprise Value | $37.37M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 3.21 | P/B Ratio | 2.21 |
| P/CF Ratio | -1.14 | P/FCF Ratio | -1.12 |
| EPS | $-2.18 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -28.66% | Gross Margin | 0.54% |
| Operating Margin | -1.59% | Profit Margin | 3.12% |
| ROE | -5.61% | ROA | 0.9% |
| ROCE | -0.81% | Current Ratio | 2.05 |
| Quick Ratio | 1.94 | Cash Ratio | 1.2 |
| Debt/Equity | 0.27 | Interest Coverage | 8.6 |
| Altman Z Score | -4.52 | Piotroski Score | 7 |